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The pathogen sensor RIG-I recognizes viral RNA and signals to induce an antiviral response. In this issue
of Cell Host & Microbe, Weber et al. (2015), along with recent work by Sato et al. (2015), demonstrate that
RIG-I directly inhibits viral replication independent of antiviral signaling.Rapid and accurate recognition of viral
invaders represents the first step to
mounting an effective immune defense.
Host factors known as pattern recogni-
tion receptors (PRRs) detect conserved
viral signatures and subsequently trigger
innate immune activation. One such
PRR, RIG-I, surveys the cytosol for viral
RNA and then signals via an adaptor pro-
tein, MAVS, to transcriptionally induce
type I and III interferons (IFNs), leading
to an antiviral state (reviewed in Chan
and Gack, 2015). Extensive evidence
has demonstrated that RIG-I is a key
sensor of many RNA virus infections. In
addition, there is increasing evidence
that RIG-I detects DNA viruses, which
also produce RNA species during their
life cycles.
Influenza A virus (IAV) is a segmented
negative-strand RNA virus of the family
Orthomyxoviridae, which causes annual
epidemics and occasional pandemic out-
breaks and thus constitutes a major
global health threat (Medina and Garcı´a-
Sastre, 2011). IAV can infect many
different host species and can occasion-
ally ‘‘jump’’ from one species to another,
potentially causing severe disease. Wild
birds are the main reservoir of IAV, and
current research is intensely focused on
the adaptation of avian IAV strains to
mammals.
In regards to innate sensing of IAV
infection, synthetic 50triphosphate-con-
taining short dsRNA, resembling the
panhandle-like RNA configuration of IAV
genomes, potently triggers RIG-I activa-
tion (Pichlmair et al., 2006). Physiologi-
cally, however, IAV genomic RNAs are
not ‘‘naked,’’ but rather packaged into
eight rod-shaped ribonucleoproteins
(RNPs), which together form the IAV
nucleocapsid. Each RNP contains viral
RNA, multiple nucleoproteins (NPs), and
the viral polymerase complex (composedof PA, PB1, and PB2). Furthermore,
IAV nucleocapsids are transported from
the site of virus entry to the nucleus,
where IAV replication takes place.
Therefore, whether RIG-I can detect
incoming IAV nucleocapsids during their
short passage through the cytoplasm
has been a longstanding question in the
field.
The work of Weber et al. (2015),
presented in this issue of Cell Host &
Microbe, demonstrates that RIG-I recog-
nizes the 50-triphosphorylated, encapsi-
dated genomic RNA of IAV in the cyto-
plasm shortly after infection (Figure 1).
To explore whether RIG-I can detect
incoming IAV nucleocapsids, the authors
treated cells with chemical inhibitors that
blocked the replication of viral genomes
or their nuclear export, thereby allowing
them to monitor RIG-I activation inde-
pendent of viral RNA synthesis. Indeed,
incoming IAV nucleocapsids triggered
RIG-I activation within 1 hr of infection.
Furthermore, RIG-I, but not the related
sensor MDA5, physically interacted with
the panhandle-RNA structure of in-
coming nucleocapsids. The authors next
asked if naturally occurring mutations in
components of the nucleocapsid affect
sensing by RIG-I. Residue 627 in the po-
lymerase subunit PB2 is an important
determinant of IAV host adaptation and
virulence (Hatta et al., 2001). Avian IAV
strains generally carry a glutamate at
this position (PB2-627E), while mamma-
lian IAV strains usually harbor a lysine
residue (PB2-627K). Weber et al. (2015)
found that nucleocapsids containing
avian-adapted PB2-627E are recognized
by human RIG-I more efficiently than
those containing mammalian-adapted
PB2-627K, suggesting that the PB2-
627K mutation in IAV has evolved to
evade RIG-I-mediated immunity in mam-
malian hosts.Cell Host & Microbe 1The authors further confirmed previous
results that showed that PB2-627K has
a higher binding affinity to IAV NP as
compared to PB2-627E, suggesting that
tighter binding of the viral polymerase
to the nucleocapsid may prevent RIG-I
from accessing viral RNA and thereby
limit antiviral restriction. Intriguingly,
gene targeting of the adaptor MAVS or
the use of a signaling-inactive mutant
of RIG-I did not affect RIG-I-mediated
restriction of avian-adapted IAV. These
results indicated that binding of RIG-I to
nucleocapsids can directly restrict IAV
infection in a signaling- and IFN-inde-
pendent manner.
In a complementary paper recently
published in Immunity, Sato et al.
(2015) support the concept that RIG-I
works double duty by functioning as
both an innate receptor and antiviral
effector protein (Figure 1). The authors
found that RIG-I senses the 50-ε stem-
loop region of the pregenomic RNA
(pgRNA) of hepatitis B virus (HBV), a
DNA virus of the family Hepadnaviridae
that is responsible for significant mor-
bidity worldwide (Liaw and Chu, 2009).
Sensing of pgRNA by RIG-I triggered
robust production of type III IFNs but
only minimal production of type I IFNs.
The authors further observed that bind-
ing of RIG-I to pgRNA inhibited access
of the HBV polymerase (P protein) to
the 50-ε stem-loop region, thereby
directly suppressing HBV replication.
In support of this direct antiviral activity
of RIG-I, a signaling-inactive mutant of
RIG-I was still able to block HBV replica-
tion, while a RIG-I mutant deficient in
RNA binding failed to do so.
Since its discovery in 2004, a plethora
of studies have cemented the impor-
tance of RIG-I in antiviral signaling and
IFN induction. The studies by Weber
et al. (2015) and Sato et al. (2015) now7, March 11, 2015 ª2015 Elsevier Inc. 285
Figure 1. RIG-I Dually Functions as an Innate Immune Sensor Inducing IFN Expression and
as a Direct Antiviral Restriction Factor
Upper panel: Ribonucleoproteins (RNPs) of the IAV nucleocapsid are composed of viral RNA, multiple
nucleoproteins (NP), and the viral polymerase complex consisting of subunits PA, PB1, and PB2. RIG-I
binds to the 50-triphosphorylated panhandle-RNA structure of RNPs during their short passage through
the cytoplasm. Binding of RIG-I to the viral RNA is modulated by residue 627 in PB2. The RNPs of mam-
malian-adapted IAV strains, harboring PB2-627K, are poorly recognized by RIG-I. The RNPs of avian-
adapted IAV strains, containing PB2-627E, are efficiently bound by RIG-I, which directly inhibits viral
replication. Furthermore, sensing of IAV RNAs by RIG-I leads to downstream signaling and induction of
IFNs. Lower panel: RIG-I binds to the 50-ε stem-loop region of the HBV pregenomic RNA (pgRNA). Binding
of RIG-I to pgRNA counteracts the interaction of the HBV polymerase (P) with the 50-ε region, thereby
directly inhibiting viral replication. Furthermore, recognition of pgRNA by RIG-I leads to signaling and
induction of predominantly type III IFN.
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sensor, but can also exert direct effector
function to restrict viral replication. For
HBV, RIG-I does so by binding the 50-ε
region of pgRNA to block binding of the
P protein. For IAV, the mechanistic de-
tails of how viral RNA binding by RIG-I
restricts virus replication are still un-
known. It could be speculated that
RIG-I disrupts binding of components of
the IAV polymerase complex to the viral
RNA. Furthermore, the binding of RIG-I
to the IAV nucleocapsid is modulated
by a well-known mammalian-adaptive
mutation: an E627K substitution in PB2,
which was previously described to allow
efficient polymerase activity in mamma-
lian cells.
While the two studies have con-
siderably advanced our understanding of
innate immune detection by RIG-I, they
also raise several important questions.
Does RIG-I displacement of viral polymer-
ase protein(s) exclusively account for its286 Cell Host & Microbe 17, March 11, 2015direct effector function, or are there other
activities of RIG-I that contribute to this
antiviral effect? What are the relative con-
tributions of RIG-I signaling and direct
effector function toward host defense?
In this regard, it is unclear whether these
two antiviral modes of RIG-I happen
simultaneously or in a temporally distinct
fashion. Finally, as several upstream regu-
latory proteins are required for RIG-I-
mediated antiviral signaling (reviewed in
Chan and Gack, 2015), it can be specu-
lated that there also exist host factors
required for direct RIG-I effector function.
Identification of such regulatory proteins
would likely reveal further mechanistic
details of how RIG-I directly restricts viral
replication.
On the virus side, it remains to be eluci-
dated whether RIG-I also restricts other
viruses via direct effector function or if
this function only applies to a small subset
of viruses. Many viruses, however, have
evolved means to block RIG-I-mediatedª2015 Elsevier Inc.antiviral signaling and IFN production.
For example, the NS1 protein of IAV
targets the ubiquitin E3 ligases TRIM25
and Riplet to inhibit RIG-I signal activation
via K63-linked ubiquitination (Rajsbaum
et al., 2012). The PB2-E627K substitution
in mammalian-adapted IAV strains sug-
gests that viruses may have also evolved
means to evade RIG-I-mediated antiviral
effector function. Furthermore, some viru-
lent strains of IAV, such as the pandemic
H1N1 virus of 2009 (pH1N1), do not
contain PB2-E627K substitutions. Artifi-
cially introducing this substitution into
pH1N1 did not increase its virulence
(Herfst et al., 2010), suggesting that other
adaptive mutations in IAV may exist to
allow evasion of direct RIG-I antiviral
function. In regards to the findings by
Sato et al. (2015), it remains unclear why
HBV infection preferentially triggers type
III, but not type I, IFN induction upon
RIG-I signaling. Recent work showing
that peroxisomal-localized MAVS medi-
ates type III IFN induction may provide a
clue to the puzzle (Odendall et al., 2014).
Alternatively, antagonistic proteins of
HBV may specifically block the RIG-I-
MAVS signaling axis that leads to type I
IFN induction.
In conclusion, these two studies pro-
vide evidence that RIG-I exerts antiviral
activity via two distinct mechanisms:
the previously well-characterized innate
sensing function of RIG-I, which leads to
IFN gene expression, and the newly
discovered antiviral effector function of
RIG-I, which blocks binding of the viral
polymerase to the RNA. A comprehensive
view of howRIG-I controls viral replication
will greatly enhance our understanding
of innate immune restriction and may
lead to novel antiviral therapies.REFERENCES
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In this issue of Cell Host & Microbe, Liu et al. (2015) and Burgess and Mohr (2015) describe how two poxvirus
mRNA decapping enzymes hijack a host 50-to-30-exoribonuclease to evade antiviral innate immunity by
limiting accumulation of double-stranded RNA.A deadly chess game is in progress be-
tween viruses and their hosts that has
extended over millions of years. Higher
vertebrates have evolved elaborate and
multilayered innate immune systems
that, when successful, suppress or other-
wise retard viral infections until the adap-
tive immune system can clear the
infection. As a consequence, to propa-
gate and spread, viruses must counteract
host innate immunity.
Among viral pathogens that infect hu-
mans, the dsDNA genome poxvirus fam-
ily includes one of the deadliest, variola
virus, the causative agent of smallpox.
Prior to development of an effective vac-
cine and its eradication in 1980, variola
virus left a trail of destruction extending
for many thousands of years. However,
for virologists, poxviruses, in particular
the smallpox vaccine strain, vaccinia vi-
rus (VACV), provide a treasure trove of
information on this topic because of their
relatively large genomes (including about
200 genes), the fact that they replicate
entirely in the cytoplasm (where many
innate immunity factors reside), and the
many fascinating ways in which they
counteract host immunity (McFadden,
2005).
To replicate and spread, poxviruses
must antagonize two potent host anti-
viral pathways: the 20,50-oligoadenylate
synthetase (OAS)/RNase L and double-stranded RNA (dsRNA)-dependent pro-
tein kinase R (PKR) systems (Sadler and
Williams, 2008) (Figure 1). Interferons
(IFNs) produced in response to viral infec-
tions induce through cell-surface recep-
tors JAK-STAT signaling, resulting in
transcription of a family of OAS genes
and a single PKR gene. DsRNA produced
by the virus activates both PKR and OAS
proteins. PKR undergoes auto-phosphor-
ylation and then it phosphorylates trans-
lation initiation factor eIF2a, inhibiting
recycling of the GDP-bound form,
causing cessation of protein synthesis.
OAS proteins produce unusual 20-to-50
linked oligoadenylates known as ‘‘2-5A’’
from ATP. 2-5A binds with monomeric
RNase L, causing it to dimerize into a
catalytically active form that internally
cleaves viral and cellular single-stranded
RNA (Dong and Silverman, 1995). There-
fore, both pathways block viral protein
synthesis but by different mechanisms;
one is direct (PKR), and the other is indi-
rect (OAS/RNase L) by degrading mRNA
and rRNA.
It has been known for 46 years that
VACV produces dsRNA from annealing
of complementary strands of viral RNA
late in the poxvirus replication cycle
(Duesberg and Colby, 1969). In perhaps
the most important advance on this topic
since then, back-to-back papers in this
issue of Cell Host & Microbe describehow VACV blunts antiviral responses by
limiting the accumulation of dsRNA
(Burgess and Mohr, 2015; Liu et al.,
2015) (Figure 1). Late (post DNA replica-
tion) in the poxvirus replication cycle,
dsRNA is formed by base-pairing be-
tween converging viral transcripts pro-
duced from opposite strands of the viral
genome. It turns out that VACV prevents
high levels of dsRNA from accumulating
through an RNA catabolic pathway
that borrows from and mimics the host
50-to-30 pathway of mRNA decay (Fig-
ure 1). In eukaryotes, a decapping
enzyme (Dcp2) containing a nudix/MutT
hydrolase motif removes m7-GDP caps
allowing the 50-to-30-exoribonuclease,
Xrn1, to progressively degrade the de-
capped 50-monophosphorylated RNAs
(Jones et al., 2012). VACV D9 and D10
proteins, nudix/MutT motif enzymes, are
involved in suppressing translation of
host mRNA, countering the host antiviral
response while reducing competition for
host translational machinery, and in main-
taining divisions between different stages
(early, intermediate, and late) of the virus-
replication cycle (see Liu et al. [2015] for
original references). D9 and D10 are early
and late proteins, respectively, which
have about 25% sequence identity and
are widely conserved among chordopox-
viruses, highlighting their importance.
However, due to their compensating7, March 11, 2015 ª2015 Elsevier Inc. 287
